{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:35:48Z","timestamp":1790166948945,"version":"4.1.0"},"reference-count":28,"publisher":"American Psychiatric Association Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2001,11,1]]},"DOI":"10.1176\/appi.ajp.158.11.1835","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:10:43Z","timestamp":1034359843000},"page":"1835-1842","source":"Crossref","is-referenced-by-count":200,"title":["Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia"],"prefix":"10.1176","volume":"158","author":[{"given":"Michael","family":"Gitlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Nuechterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Subotnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Fogelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bartzokis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manickam","family":"Aravagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R15811BAJFHJJD","doi-asserted-by":"crossref","unstructured":"Gilbert PL, Harris MJ, McAdams LA, Jeste DV: Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry 1995; 52:173-188","DOI":"10.1001\/archpsyc.1995.03950150005001"},{"key":"R15811BAJDJHIB","doi-asserted-by":"crossref","unstructured":"Scottish Schizophrenia Research Group: The Scottish first episode schizophrenia study. Br J Psychiatry 1987; 150:334-338","DOI":"10.1192\/bjp.150.3.334"},{"key":"R15811BAJCGIGC","doi-asserted-by":"crossref","unstructured":"Kane J, Rifkin A, Quitkin F, Devdutt N, Ramos-Lorenzi J: Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatry 1982; 39:70-73","DOI":"10.1001\/archpsyc.1982.04290010048009"},{"key":"R15811BAJJAEHC","doi-asserted-by":"crossref","unstructured":"Crow TJ, MacMillan JF, Johnson AL, Johnstone EC: A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986; 148:120-127","DOI":"10.1192\/bjp.148.2.120"},{"key":"R15811BAJIHADE","doi-asserted-by":"crossref","unstructured":"Robinson D, Woerner MG, Alvir JMJ, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos MH, Mayerhoff D, Lieberman JA: Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56:241-247","DOI":"10.1001\/archpsyc.56.3.241"},{"key":"R15811BAJBIJIB","doi-asserted-by":"crossref","unstructured":"Nuechterlein KH, Gitlin MJ, Subotnik KL: The early course of schizophrenia and long-term maintenance neuroleptic therapy. Arch Gen Psychiatry 1995; 52:203-205","DOI":"10.1001\/archpsyc.1995.03950150035006"},{"key":"R15811BAJDHDIH","doi-asserted-by":"crossref","unstructured":"Falloon IRH: Relapse: a reappraisal of assessment of outcome in schizophrenia. Schizophr Bull 1984; 10:293-299","DOI":"10.1093\/schbul\/10.2.293"},{"key":"R15811BAJDCIEE","doi-asserted-by":"crossref","unstructured":"Sheitman BB, Lee H, Strauss R, Lieberman JA: The evaluation and treatment of first-episode psychosis. Schizophr Bull 1997; 23:653-661","DOI":"10.1093\/schbul\/23.4.653"},{"key":"R15811BAJIGCEI","doi-asserted-by":"crossref","unstructured":"Lehman AF, Steinwachs DM, Dixon LB, Goldman HH, Osher F, Postrado L, Scott JE, Thompson JW, Fahey M, Fischer P, Kasper JA, Lyles A, Skinner EA, Buchanan R, Carpenter WT Jr, Levine J, McGlynn EA, Rosenheck R, Zito J: Translating research into practice: the schizophrenia patient outcomes research team (PORT) treatment recommendations. Schizophr Bull 1998; 24:1-10","DOI":"10.1093\/oxfordjournals.schbul.a033302"},{"key":"R15811BAJIHCGI","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, Buchanan RW: Continuous versus targeted medication in schizophrenic outpatients: outcome results. Am J Psychiatry 1990; 147:1138-1148; correction, 148:819","DOI":"10.1176\/ajp.147.9.1138"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Heinrichs DW: Early intervention, time-limited, targeted pharmacotherapy of schizophrenia. Schizophr Bull 1983; 9:533-542","DOI":"10.1093\/schbul\/9.4.533"},{"key":"R15811BAJCEAJF","doi-asserted-by":"crossref","unstructured":"Herz MI, Glazer W, Mostert MA, Sheard MA, Szymanski HV, Hafez H, Mirza M, Vana J: Intermittent vs maintenance medication in schizophrenia. Arch Gen Psychiatry 1991; 48:333-339","DOI":"10.1001\/archpsyc.1991.01810280049007"},{"key":"R15811BAJJIDFE","doi-asserted-by":"crossref","unstructured":"Nuechterlein KH, Dawson ME, Gitlin M, Ventura J, Goldstein MJ, Snyder KS, Yee CM, Mintz J: Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 1992; 18:392-425","DOI":"10.1093\/schbul\/18.3.387"},{"key":"R15811BAJBIGHB","doi-asserted-by":"crossref","unstructured":"Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35:773-782","DOI":"10.1001\/archpsyc.1978.01770300115013"},{"key":"R15811BAJJHCHA","unstructured":"Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green MF, Shaner A: Appendix 1: Brief Psychiatric Rating Scale (BPRS) expanded version (4.0) scales, anchor points and administration manual. Int J Methods in Psychiatr Res 1993; 3:227-243"},{"key":"R15811BAJHHGHF","unstructured":"Ventura J, Green MF, Shaner A, Liberman RP: Training and quality assurance with the Brief Psychiatric Rating Scale: the \u201cdrift busters.\u201d Int J Methods in Psychiatr Res 1993; 3:221-224"},{"key":"R15811BAJDGHFJ","unstructured":"Midha KK, Cooper JK, Hubbard JW: Radioimmunoassay for fluphenazine in human plasma. Commun Psychopharmacol 1980; 4:102-114"},{"key":"R15811BAJCCDBJ","doi-asserted-by":"crossref","unstructured":"McKay G, Steeves T, Cooper JK, Hawes EM, Midha KK: Development and application of a radioimmunoassay for fluphenazine based on monoclonal antibodies and its comparison with alternate methods. J Pharm Sci 1990; 79:240-243","DOI":"10.1002\/jps.2600790313"},{"key":"R15811BAJDBJHI","doi-asserted-by":"crossref","unstructured":"Gitlin M, Midha KK, Fogelson DL, Nuechterlein KH: Persistence of fluphenazine in plasma after decanoate withdrawal. J Clin Psychopharmacol 1988; 8:53-56","DOI":"10.1097\/00004714-198802000-00010"},{"key":"R15811BAJJJHCJ","doi-asserted-by":"crossref","unstructured":"Ruskin PE, Nyman G: Discontinuation of neuroleptic medication in older, outpatient schizophrenics. J Nerv Ment Dis 1991; 179:212-214","DOI":"10.1097\/00005053-199104000-00006"},{"key":"R15811BAJCFGBF","doi-asserted-by":"crossref","unstructured":"Glovinsky D, Kirch DG, Wyatt RJ: Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients. Biol Psychiatry 1992; 31:968-970","DOI":"10.1016\/0006-3223(92)90124-I"},{"key":"R15811BAJCEDCE","doi-asserted-by":"crossref","unstructured":"Wyatt RJ, Henter ID: The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J Psychiatr Res 1998; 32:169-177","DOI":"10.1016\/S0022-3956(97)00014-9"},{"key":"R15811BAJGGCIG","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr: New views on the course and treatment of schizophrenia. J Psychiatr Res 1998; 32:191-195","DOI":"10.1016\/S0022-3956(97)00037-X"},{"key":"R15811BAJBCIHG","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Schooler NR, Kane JM: The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry 1997; 54:401-407","DOI":"10.1001\/archpsyc.1997.01830170015002"},{"key":"R15811BAJBGHAE","doi-asserted-by":"crossref","unstructured":"Craig TJ, Bromet EJ, Fennig S, Tanenberg-Karant M, Lavelle J, Galambos N: Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series? Am J Psychiatry 2000; 157:60-66","DOI":"10.1176\/ajp.157.1.60"},{"key":"R15811BAJGDCDC","doi-asserted-by":"crossref","unstructured":"Marder SM, Wirshing WC, Van Putten T, Mintz J, McKenzie J, Johnston-Cronk K, Lebell M, Liberman RP: Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia. Arch Gen Psychiatry 1994; 51:280-287","DOI":"10.1001\/archpsyc.1994.03950040024003"},{"key":"R15811BAJEGEHG","doi-asserted-by":"crossref","unstructured":"Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Lann HD, Breier AF, Summerfelt AT: Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks. Am J Psychiatry 1999; 156:412-418","DOI":"10.1176\/ajp.156.3.412"},{"key":"R15811BAJDJHGB","doi-asserted-by":"crossref","unstructured":"Kapur S, Remington G: Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Ann Rev Med 2001; 52:503-517","DOI":"10.1146\/annurev.med.52.1.503"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.11.1835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T12:07:28Z","timestamp":1722168448000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.11.1835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11,1]]}},"alternative-id":["10.1176\/appi.ajp.158.11.1835"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.158.11.1835","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}